DNA-driven nutritional therapy of inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nutrition (Burbank, Los Angeles County, Calif.)

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nut.2009.06.011PMID 19647622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Inflammatory Bowel Disease

  2014cited by this paper
• Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’

  2009cited by this paper
• Pathogenesis of and Unifying Hypothesis for Idiopathic Pouchitis

  2009cited by this paper
• Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.

  2009cited by this paper
• Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa

  2009cited by this paper
• Ulcerative colitis loci on chromosomes 1 p 36 and 12 q 15 identified by genome-wide association study

  2009cited by this paper
• Live and Heat-Killed Lactobacillus rhamnosus GG: Effects on Proinflammatory and Anti-Inflammatory Cytokines/Chemokines in Gastrostomy-Fed Infant Rats

  2009cited by this paper
• Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ Nutrition in Crohn's disease

  2009cited by this paper
• Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids.

  2009cited by this paper
• Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.

  2008cited by this paper
• Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility.

  2008cited by this paper
• Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL‐22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status

  2008cited by this paper
• Genome-wide association studies for complex traits: consensus, uncertainty and challenges

  2008cited by this paper
• Understanding the Nutrigenomic Definitions and Concepts at the Food–Genome Junction

  2008cited by this paper
• Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism

  2008cited by this paper
• Conclusions and recommendations from the symposium, Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids.

  2008cited by this paper
• Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.

  2008cited by this paper
• Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort

  2008cited by this paper
• Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases

  2008cited by this paper
• The genetics and immunopathogenesis of inflammatory bowel disease

  2008cited by this paper
• Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial

  2008cited by this paper
• OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease.

  2008cited by this paper
• Body traffic: ecology, genetics, and immunity in inflammatory bowel disease.

  2007cited by this paper
• Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept.

  2007cited by this paper
• Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

  2007cited by this paper
• Enteral nutrition for maintenance of remission in Crohn's disease.

  2007cited by this paper
• CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.

  2007cited by this paper
• Cell culture models in developing nutrigenomics foods for inflammatory bowel disease.

  2007cited by this paper
• IL‐23 receptor (IL‐23R) gene protects against pediatric Crohn's disease

  2007cited by this paper
• The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer.

  2007cited by this paper
• Importance of microbial colonization of the gut in early life to the development of immunity.

  2007cited by this paper
• Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets.

  2007cited by this paper
• Imbalances in Dietary Consumption of Fatty Acids, Vegetables, and Fruits Are Associated With Risk for Crohn's Disease in Children

  2007cited by this paper
• Phenotypic and functional features of human Th17 cells

  2007cited by this paper
• Enteral nutritional therapy for induction of remission in Crohn's disease.

  2007cited by this paper
• Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility

  2007cited by this paper
• The fundamental basis of inflammatory bowel disease.

  2007cited by this paper
• Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine

  2007cited by this paper
• Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.

  2007cited by this paper
• Nutrigenomics in the whole-genome scanning era: Crohn’s disease as example

  2007cited by this paper
• CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.

  2006cited by this paper
• Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy

  2006cited by this paper
• Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

  2006cited by this paper
• Influence of human genetic variation on nutritional requirements.

  2006cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.

  2006cited by this paper
• The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis

  2006cited by this paper
• Enteric Flora in Health and Disease

  2006cited by this paper
• Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis.

  2006cited by this paper
• Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants

  2006cited by this paper
• Nutrition in inflammatory bowel disease.

  2006cited by this paper
• Impact of Elemental Diet on Mucosal Inflammation in Patients with Active Crohn's Disease: Cytokine Production and Endoscopic and Histological Findings

  2005cited by this paper
• Genome-wide association studies for common diseases and complex traits

  2005cited by this paper
• NOD2 and Crohn's disease: loss or gain of function?

  2005cited by this paper
• Diet and rheumatoid arthritis: a review of the literature.

  2005cited by this paper
• Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

  2004cited by this paper
• Functional variants of OCTN cation transporter genes are associated with Crohn disease

  2004cited by this paper
• Polymorphisms of the Interleukin-1&bgr; Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro

  2004cited by this paper
• Dietary modulation of the human colonic microbiota: updating the concept of prebiotics

  2004cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2004cited by this paper
• Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects.

  2003cited by this paper
• Review article: nutrition and adult inflammatory bowel disease.

  2003cited by this paper
• Effects of Nonpathogenic Bacteria on Cytokine Secretion by Human Intestinal Mucosa

  2003cited by this paper
• Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

  2003cited by this paper
• Nutrition and cancer prevention: diet-gene interactions

  2003cited by this paper
• MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

  2002cited by this paper
• The molecular classification of the clinical manifestations of Crohn's disease.

  2002cited by this paper
• Epidemiology of inflammatory bowel disease.

  2002cited by this paper
• Folates and prevention of disease

  2001cited by this paper
• Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

  2001cited by this paper
• The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis.

  2001cited by this paper
• The urban diet and Crohn's disease: is there a relationship?

  2001cited by this paper
• Allelic variation at the interleukin 1β gene is associated with decreased bone mass in patients with inflammatory bowel diseases

  2001cited by this paper
• A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

  2001cited by this paper
• Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial

  2000cited by this paper
• Microflora‐associated characteristics in faeces from allergic and nonallergic infants

  2000cited by this paper
• Nutrition in Crohn's disease.

  2000cited by this paper
• Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer

  1998cited by this paper
• The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.

  1997cited by this paper
• Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.

  1997cited by this paper
• Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease.

  1996cited by this paper
• Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men.

  1995cited by this paper
• Diet and Inflammatory Bowel Disease: A Case-Control Study

  1992cited by this paper

• The Importance of Nutriepigenetics in Older Adults with Inflammatory Bowel Disease

  2025cites this paper
• Associations between eicosapentaenoic acid and docosahexaenoic acid consumption and inflammatory bowel disease in adults: The National Health and Nutrition Examination Survey (NHANES) 2009-2010.

  2024cites this paper
• Modern nutrigenomics and nutrigenetics and some metabolic aspects of pathogenesis in inflammatory bowel diseases: a look into the future

  2020cites this paper
• Omics technologies and the choice of treatment strategy for inflammatory intestinal diseases

  2018cites this paper
• Epigenetics of Crohn’s Disease, Ulcerative Colitis, and Phenotypically Normal Individuals

  2017cites this paper
• Why might the finding of a new genetic association with inflammatory bowel disease be of potential value in disease control?

  2017cites this paper
• Mucosal MicroRNAs Expression Profiles before and after Exclusive Enteral Nutrition Therapy in Adult Patients with Crohn’s Disease

  2016cites this paper
• Inflammatory bowel disease

  2015cites this paper
• Inflammatory Bowel Diseases: What Do We Still Need to Investigate?

  2015cites this paper
• Enfermedad inflamatoria intestinal, hacia la nutrición personalizada

  2014cites this paper
• Preoperative Optimization of Crohn Disease

  2013cites this paper
• Nutrition management in the adult patient with Crohn’s disease

  2012cites this paper
• Biomarkers of Nutrient Bioactivity and Efficacy: A Route Toward Personalized Nutrition

  2012cites this paper
• Environmental Factors in the Epidemiology of Inflammatory Bowel Disease

  2012cites this paper
• Nutrition in Inflammatory Bowel Disease

  2012cites this paper
• Nutrition management in the adult patient with Crohn’s disease

  2012cites this paper
• Inflammatory bowel disease: role of diet, microbiota, life style.

  2012influential citation
• NUTRITION AND INFLAMMATORY BOWEL DISEASE

  2012cites this paper
• Nutritional Genomics: Nutrigenetics and Nutrigenomics

  2012cites this paper
• Nutritional treatment in inflammatory bowel disease. An update.

  2012cites this paper
• Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated Fatty acids with comparison to transcriptomic analysis.

  2012cites this paper
• Pharmacological oils for identification to target Inflammatory

  2012cites this paper
• Inflammatory Diseases - A Modern Perspective

  2011cites this paper
• The Effects of n-3 Polyunsaturated Fatty Acid-Rich Salmon on Inflammatory Bowel Diseases

  2011cites this paper
• Overview of Genomics and Gastrointestinal Health and Disease

  2011cites this paper
• Nutritional support of surgical patients with inflammatory bowel disease.

  2011cites this paper
• Stevia: It‘s Not Just About Calories~!2009-07-28~!2010-05-19~!2010-07-21~!

  2010cites this paper
• Nutrigenomics and inflammatory bowel diseases

  2010cites this paper
• Understanding the Nutrigenomic Definitions and Concepts at the Food–Genome Junction

  2008cites this paper